Prevalence of nephropathy among diabetic patients in North American region: A systematic review and meta-analysis.

IF 1.3 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Medicine Pub Date : 2024-09-20 DOI:10.1097/MD.0000000000039759

Sabahat Zahra, Muhammad Khurram Saleem, Khawaja Faizan Ejaz, Amna Akbar, Sarosh Khan Jadoon, Shoukat Hussain, Amir Iqbal Ali, Mehzabeen Ifty, Sadia Zafur Jannati, Fariza Armin, Deepannita Sarker, Dewan Zubaer Islam, Shahad Saif Khandker, Mohammad Saleem Khan, Sarosh Alvi

{"title":"Prevalence of nephropathy among diabetic patients in North American region: A systematic review and meta-analysis.","authors":"Sabahat Zahra, Muhammad Khurram Saleem, Khawaja Faizan Ejaz, Amna Akbar, Sarosh Khan Jadoon, Shoukat Hussain, Amir Iqbal Ali, Mehzabeen Ifty, Sadia Zafur Jannati, Fariza Armin, Deepannita Sarker, Dewan Zubaer Islam, Shahad Saif Khandker, Mohammad Saleem Khan, Sarosh Alvi","doi":"10.1097/MD.0000000000039759","DOIUrl":null,"url":null,"abstract":"Background: Nephropathy is one of the most common microvascular impediments of diabetes mellitus. In this study, we aimed to estimate the prevalence of nephropathy in diabetic patients across the North American region.Methods: Eligible studies were screened out from 3 electronic databases, for example, PubMed, Google Scholar, and ScienceDirect using specific search keywords based on the eligibility criteria. Extracting the data from the included studies publication bias, quality assessment, outlier investigation, and meta-analysis was done followed by the subgroup analysis. A total of 11 studies met the study inclusion criteria. Meta-analysis was performed with the extracted data.Results: Pooled prevalence of 28.2% (95% confidence interval [CI]: 19.7-36.7) with a high rate of heterogeneity (I2 = 100%) was identified. The pooled prevalence of nephropathy among diabetic patients in the United States of America, Canada, and Mexico was 24.2% (95% CI: 13.8-34.5), 31.2% (95% CI: 25.8-36.5), and 31.1% (95% CI: 20.8-41.5), respectively.Conclusion: The prevalence of nephropathy among diabetic patients was found lower in the United States of America as compared to Canada and Mexico. Besides, the pooled prevalence of the North American region was found to be lower as compared to the African, European, and Asian regions. Minimizing the pathogenic factors, sufficient diagnostic, healthcare facilities, and awareness are recommended to improve the situation.","PeriodicalId":18549,"journal":{"name":"Medicine","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11419527/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MD.0000000000039759","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Nephropathy is one of the most common microvascular impediments of diabetes mellitus. In this study, we aimed to estimate the prevalence of nephropathy in diabetic patients across the North American region.

Methods: Eligible studies were screened out from 3 electronic databases, for example, PubMed, Google Scholar, and ScienceDirect using specific search keywords based on the eligibility criteria. Extracting the data from the included studies publication bias, quality assessment, outlier investigation, and meta-analysis was done followed by the subgroup analysis. A total of 11 studies met the study inclusion criteria. Meta-analysis was performed with the extracted data.

Results: Pooled prevalence of 28.2% (95% confidence interval [CI]: 19.7-36.7) with a high rate of heterogeneity (I2 = 100%) was identified. The pooled prevalence of nephropathy among diabetic patients in the United States of America, Canada, and Mexico was 24.2% (95% CI: 13.8-34.5), 31.2% (95% CI: 25.8-36.5), and 31.1% (95% CI: 20.8-41.5), respectively.

Conclusion: The prevalence of nephropathy among diabetic patients was found lower in the United States of America as compared to Canada and Mexico. Besides, the pooled prevalence of the North American region was found to be lower as compared to the African, European, and Asian regions. Minimizing the pathogenic factors, sufficient diagnostic, healthcare facilities, and awareness are recommended to improve the situation.

查看原文本刊更多论文

北美地区糖尿病患者肾病患病率：系统回顾和荟萃分析。

背景：肾病是糖尿病最常见的微血管障碍之一。本研究旨在估算北美地区糖尿病患者的肾病患病率：根据资格标准，使用特定的搜索关键词从 PubMed、Google Scholar 和 ScienceDirect 等 3 个电子数据库中筛选出符合条件的研究。从纳入的研究中提取数据，进行出版偏倚、质量评估、离群值调查和荟萃分析，然后进行亚组分析。共有 11 项研究符合研究纳入标准。对提取的数据进行了元分析：结果：汇总患病率为 28.2%（95% 置信区间 [CI]：19.7-36.7），异质性较高（I2 = 100%）。美国、加拿大和墨西哥糖尿病患者肾病的总患病率分别为24.2%（95% CI：13.8-34.5）、31.2%（95% CI：25.8-36.5）和31.1%（95% CI：20.8-41.5）：结论：与加拿大和墨西哥相比，美国糖尿病患者的肾病患病率较低。此外，北美地区的综合患病率也低于非洲、欧洲和亚洲地区。为改善这一状况，建议尽量减少致病因素，提供足够的诊断和医疗设施，并提高人们的认识。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Medicine 医学-医学：内科

CiteScore

2.80

自引率

0.00%

发文量

4342

审稿时长

>12 weeks

期刊介绍： Medicine is now a fully open access journal, providing authors with a distinctive new service offering continuous publication of original research across a broad spectrum of medical scientific disciplines and sub-specialties. As an open access title, Medicine will continue to provide authors with an established, trusted platform for the publication of their work. To ensure the ongoing quality of Medicine’s content, the peer-review process will only accept content that is scientifically, technically and ethically sound, and in compliance with standard reporting guidelines.